Common blood pressure drug could make cancer therapy far more powerful
Researchers found that the common blood pressure drug telmisartan can significantly improve the performance of the cancer drug olaparib, potentially expanding its benefits beyond patients with BRCA-related tumors. The combination is already being tested in human clinical trials a
Researchers found that the common blood pressure drug telmisartan can significantly improve the performance of the cancer drug olaparib, potentially expanding its benefits beyond patients with BRCA-related tumors. The combination is already being tested in human clinical trials a This story matters for Health & Wellness readers tracking wellness. Reported by sciencedaily.com. Read the full original at the source link below.
Originally reported by sciencedaily.com. WellnessNews curates and briefs the health & wellness stories that matter. Our editorial policy →